Skip to main content

Clinical & Experimental Metastasis OnlineFirst articles

Open Access 18-05-2024 | Review

Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis

Although progress has been made in the treatment of cancer, particularly for the four major types of cancers affecting the lungs, colon, breast and prostate, resistance to cancer treatment often emerges upon inhibition of major signaling pathways …

Authors:
Lisa-Marie Mehner, Leonel Munoz-Sagredo, Steffen Joachim Sonnentag, Sven Máté Treffert, Véronique Orian-Rousseau

Open Access 08-05-2024 | Metastasis | Research

A new Neu—a syngeneic model of spontaneously metastatic HER2-positive breast cancer

Metastatic disease results from the dissemination of tumor cells beyond their organ of origin to grow in distant organs and is the primary cause of death in patients with advanced breast cancer. Preclinical murine models in which primary tumors …

Authors:
Aaron G. Baugh, Edgar Gonzalez, Valerie H. Narumi, Jesse Kreger, Yingtong Liu, Christine Rafie, Sofi Castanon, Julie Jang, Luciane T. Kagohara, Dimitra P. Anastasiadou, James Leatherman, Todd Armstrong, Isaac Chan, George S. Karagiannis, Elizabeth M. Jaffee, Adam MacLean, Evanthia T. Roussos Torres

29-04-2024 | Melanoma | Review

Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors

Epigenetic mechanisms have been shown to play an important role in the development of cancer. These include the activation of chromatin remodeling factors in various malignancies, including bromodomain plant homeodomain (PHD) finger transcription …

Authors:
Imran Khan, Mohammed Kashani-Sabet

13-04-2024 | Neuroblastoma | Research

Predictive value of 18 F-FDG PET/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma

Neuroblastoma (NB) is the most prevalent solid extracranial malignancy and primarily affects children under the age of 5. It accounts for 8-10% of childhood malignancies and contributes to 15% of the total mortality rate associated with childhood …

Authors:
Zhenzhen Zhao, Chao Yang

Open Access 12-04-2024 | Cytostatic Therapy | Research

Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancer

Chemotherapy drugs efficiently eradicate rapidly dividing differentiated cells by inducing cell death, but poorly target slowly dividing cells, including cancer stem cells and dormant cancer cells, in the later course of treatment. Prolonged …

Authors:
Vugar Yagublu, Bayram Bayramov, Christoph Reissfelder, Javahir Hajibabazade, Shalala Abdulrahimli, Michael Keese

06-04-2024 | Metastasis | Review

Stress-induced phosphoprotein 1: how does this co-chaperone influence the metastasis steps?

In several cancer types, metastasis is associated with poor prognosis, survival, and quality of life, representing a life risk more significant than the primary tumor itself. Metastasis is a multi-step process that spreads tumor cells from primary …

Authors:
Alexandre Luiz Korte de Azevedo, Talita Helen Bombardelli Gomig, Enilze Maria de Souza Fonseca Ribeiro

Open Access 06-04-2024 | Breast Cancer | Research

Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis

Patients with triple-negative breast cancer (TNBC) have an increased propensity to develop lung metastasis. Our previous studies demonstrated that stem-like ALDHhiCD44+ breast cancer cells interact with lung-derived soluble factors, resulting in …

Authors:
Vasudeva Bhat, Matthew Piaseczny, David Goodale, Urvi Patel, Ashkan Sadri, Alison L. Allan

03-04-2024 | Hashimoto Thyroiditis | Research

Nomogram to predict central lymph node metastasis in papillary thyroid carcinoma

Central lymph node metastasis (CLNM) of papillary thyroid carcinoma (PTC) is common. In our study, we built a nomogram to predict CLNM. We retrospectively analyzed 1,392 PTC patients. This group of patients was divided into a training cohort …

Authors:
Dehui Qiao, Xian Deng, Ruichen Liang, Xu Li, Rongjia Zhang, Zhi Lei, Hui Yang, Xiangyu Zhou

Open Access 29-03-2024 | Metastasis | Research

Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases

Metastatic breast cancer (mBC) remains incurable and liver metastases (LM) are observed in approximately 50% of all patients with mBC. In some cases, surgical resection of breast cancer liver metastases (BCLM) is associated with prolonged …

Authors:
Sophia Leduc, Ha-Linh Nguyen, François Richard, Gitte Zels, Amena Mahdami, Maxim De Schepper, Marion Maetens, Anirudh Pabba, Joris Jaekers, Emily Latacz, Ali Bohlok, Evy Vanderheyden, Thomas Van Brussel, Bram Boeckx, Rogier Schepers, Diether Lambrechts, Luc Dirix, Denis Larsimont, Sophie Vankerckhove, Valerio Lucidi, Baki Topal, Imane Bachir, Vincent Donckier, Giuseppe Floris, Peter Vermeulen, Christine Desmedt

Open Access 23-03-2024 | Metastasis | Review

How much do we know about the metastatic process?

Cancer cells can leave their primary sites and travel through the circulation to distant sites, where they lodge as disseminated cancer cells (DCCs), even during the early and asymptomatic stages of tumor progression. In experimental models and …

Authors:
Carolina Rodriguez-Tirado, Maria Soledad Sosa

Open Access 23-03-2024 | Metastasis | Editorial

Forty years on: a brief history of clinical and experimental metastasis

Authors:
Jonathan P. Sleeman, Jörg Haier

Open Access 18-03-2024 | Metastasis | Research

TGFβ signalling pathway impacts brain metastases profiles in locally advanced colorectal cancer

Colorectal Cancer (CRC) represents the third most common type of cancer in Germany and the second most common cancer-related cause of death worldwide. With more than 25% of CRC being diagnosed in distant metastatic state, one of the decisive …

Authors:
Sven Jacob, Ilja Balonov, Vindi Jurinovic, Christian Heiliger, Tengis Tschaidse, Jörg Kumbrink, Thomas Kirchner, Jens Werner, Martin K. Angele, Marlies Michl, Jens Neumann

Open Access 15-03-2024 | Breast Cancer | Review

The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria

As a major energy source for cells, mitochondria are involved in cell growth and proliferation, as well as migration, cell fate decisions, and many other aspects of cellular function. Once thought to be irreparably defective, mitochondrial …

Authors:
Sarah Libring, Emily D. Berestesky, Cynthia A. Reinhart-King

Open Access 11-03-2024 | Metastasis | Review

Current pharmacologic treatment of brain metastasis in non-small cell lung cancer

Lung cancer is a type of cancer that can metastasize to the lungs, brain, bones, liver, adrenal glands, and other organs; however, the occurrence of brain metastases is the most common event. Symptoms of brain metastasis include motor dysfunction …

Authors:
Takae Okuno, Takeshi Isobe, Yukari Tsubata

02-03-2024 | Metastasis | Review

From pre-clinical to translational brain metastasis research: current challenges and emerging opportunities

Brain metastasis, characterized by poor clinical outcomes, is a devastating disease. Despite significant mechanistic and therapeutic advances in recent years, pivotal improvements in clinical interventions have remained elusive. The heterogeneous …

Authors:
Emilija Aleksandrovic, Siyuan Zhang, Dihua Yu

Open Access 28-02-2024 | Metastasis | Editorial

Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis

Authors:
Stanley P. Leong, S. David Nathanson, Jonathan S. Zager

Open Access 28-02-2024 | Lung Cancer | Research

Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer

High rates of mortality in non-small cell lung cancer lung cancer is due to inherent and acquired resistance to systemic therapies and subsequent metastatic burden. Metastasis is supported by suppression of the immune system at secondary organs …

Authors:
A. P. Wiegmans, E. Ivanova, V. Y. Naei, J. Monkman, J. Fletcher, W. Mullally, M. E. Warkiani, K. O’Byrne, A. Kulasinghe

05-02-2024 | Metastasis | Review

Interrogating the roles of lymph node metastasis in systemic immune surveillance

Lymph nodes (LNs) are principal orchestrators of the adaptive immune response, yet in the context of malignancy, they are typically the first sites of metastasis. When tumors spread to LNs, they alter the immune repertoire, ultimately …

Authors:
Pamela A. Basto, Nathan E. Reticker-Flynn

28-01-2024 | Melanoma | Review

Neoadjuvant therapy for resectable melanoma

The standard of care for patients with resectable stage III/IV melanoma classically included upfront resection with adjuvant therapy. However, in more recent years, the amount of systemic therapies available for neoadjuvant use for these patients …

Authors:
Cimarron E. Sharon, Giorgos C. Karakousis

Open Access 28-01-2024 | Review

Clinical applications of circulating tumor cells in patients with solid tumors

The concept of liquid biopsy analysis has been established more than a decade ago. Since the establishment of the term, tremendous advances have been achieved and plenty of methods as well as analytes have been investigated in basic research as …

Authors:
Daniel J. Smit, Svenja Schneegans, Klaus Pantel